APO Research
Talk to an analyst

APO RESEARCH · REPORT

Tetrapeptide-30

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Tetrapeptide-30 Industry Growth and Trends Forecast to 2032

27 December 202597 pages

Choose your research edition.

Industry ResearchTetrapeptide-30 Industry Research Report 2026123 pages · $2,950 USDIndustry Growth & TrendsGlobal Tetrapeptide-30 Industry Growth and Trends Forecast to 203297 pages · $3,450 USDMarket StructureGlobal Tetrapeptide-30 Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032181 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Tetrapeptide-30 Market Outlook and Growth Opportunities 2026191 pages · $4,250 USDMarket Analysis & ForecastGlobal Tetrapeptide-30 Market Analysis and Forecast 2026-2032201 pages · $4,950 USD

Market perspective

The global Tetrapeptide-30 market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Tetrapeptide-30 is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Tetrapeptide-30 is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Tetrapeptide-30 is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Tetrapeptide-30 include GenScript, Spec-Chem, Uniproma Chemical, Shenzhen JYMed Technology, Zhejiang Peptites Biotech, Winkey Technology, Shenzhen Readline Biotech, Bankpeptide Biological Technology and Chengdu Youngshe Chemical, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Tetrapeptide-30 market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Tetrapeptide-30 market size, estimates, and forecasts are presented in terms of sales volume (Kg) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Tetrapeptide-30 market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Tetrapeptide-30.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Tetrapeptide-30 market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Tetrapeptide-30 Market by Company

GenScript

Spec-Chem

Uniproma Chemical

Shenzhen JYMed Technology

Zhejiang Peptites Biotech

Winkey Technology

Shenzhen Readline Biotech

Bankpeptide Biological Technology

Chengdu Youngshe Chemical

Tetrapeptide-30 Segment by Type

Purity Above 98%

Purity 98%

Tetrapeptide-30 Segment by Application

Cream

Lotion

Others

Tetrapeptide-30 Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Tetrapeptide-30 market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Tetrapeptide-30 and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Tetrapeptide-30.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Tetrapeptide-30 manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Tetrapeptide-30 in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Purity Above 98% Table 2. Major Company of Purity 98% Table 3. Global Tetrapeptide-30 Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Tetrapeptide-30 Sales by Type (2021-2026) & (Kg) Table 5. Global Tetrapeptide-30 Sales Market Share in Volume by Type (2021-2026) Table 6. Global Tetrapeptide-30 Sales by Type (2021-2026) & (US$ Million) Table 7. Global Tetrapeptide-30 Sales Market Share in Value by Type (2021-2026) Table 8. Global Tetrapeptide-30 Price by Type (2021-2026) & (US$/g) Table 9. Global Tetrapeptide-30 Sales by Type (2027-2032) & (Kg) Table 10. Global Tetrapeptide-30 Sales Market Share in Volume by Type (2027-2032) Table 11. Global Tetrapeptide-30 Sales by Type (2027-2032) & (US$ Million) Table 12. Global Tetrapeptide-30 Sales Market Share in Value by Type (2027-2032) Table 13. Global Tetrapeptide-30 Price by Type (2027-2032) & (US$/g) Table 14. North America Tetrapeptide-30 Sales by Type (2021-2026) & (Kg) Table 15. North America Tetrapeptide-30 Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Tetrapeptide-30 Sales by Type (2021-2026) & (Kg) Table 17. Europe Tetrapeptide-30 Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Tetrapeptide-30 Sales by Type (2021-2026) & (Kg) Table 19. Asia-Pacific Tetrapeptide-30 Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Tetrapeptide-30 Sales by Type (2021-2026) & (Kg) Table 21. Latin America Tetrapeptide-30 Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Tetrapeptide-30 Sales by Type (2021-2026) & (Kg) Table 23. Middle East and Africa Tetrapeptide-30 Sales by Type (2021-2026) & (US$ Million) Table 24. Tetrapeptide-30 Industry Trends Table 25. Tetrapeptide-30 Industry Drivers Table 26. Tetrapeptide-30 Industry Opportunities and Challenges Table 27. Tetrapeptide-30 Industry Restraints Table 28. Global Tetrapeptide-30 Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Tetrapeptide-30 Revenue Market Share by Company (2021-2026) Table 30. Global Tetrapeptide-30 Sales by Company (2021-2026) & (Kg) Table 31. Global Tetrapeptide-30 Sales Share by Company (2021-2026) Table 32. Global Tetrapeptide-30 Market Price by Company (2021-2026) & (US$/g) Table 33. Global Tetrapeptide-30 Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Tetrapeptide-30 Major Company Production Sites and Headquarters Table 35. Global Tetrapeptide-30 Company, Product Type & Application Table 36. Global Tetrapeptide-30 Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Tetrapeptide-30 by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Tetrapeptide-30 Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Tetrapeptide-30 Sales by Region (2021-2026) & (Kg) Table 41. Global Tetrapeptide-30 Sales Market Share in Volume by Region (2021-2026) Table 42. Global Tetrapeptide-30 Sales by Region (2021-2026) & (US$ Million) Table 43. Global Tetrapeptide-30 Sales Market Share in Value by Region (2021-2026) Table 44. Global Tetrapeptide-30 Sales (Kg), Value (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 45. Global Tetrapeptide-30 Sales by Region (2027-2032) & (Kg) Table 46. Global Tetrapeptide-30 Sales Market Share in Volume by Region (2027-2032) Table 47. Global Tetrapeptide-30 Sales by Region (2027-2032) & (US$ Million) Table 48. Global Tetrapeptide-30 Sales Market Share in Value by Region (2027-2032) Table 49. Global Tetrapeptide-30 Sales (Kg), Value (US$ Million), Price (US$/g) and Gross Margin (2027-2032) Table 50. Global Tetrapeptide-30 Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Tetrapeptide-30 Sales by Application (2021-2026) & (Kg) Table 52. Global Tetrapeptide-30 Sales Market Share in Volume by Application (2021-2026) Table 53. Global Tetrapeptide-30 Sales by Application (2021-2026) & (US$ Million) Table 54. Global Tetrapeptide-30 Sales Market Share in Value by Application (2021-2026) Table 55. Global Tetrapeptide-30 Price by Application (2021-2026) & (US$/g) Table 56. Global Tetrapeptide-30 Sales by Application (2027-2032) & (Kg) Table 57. Global Tetrapeptide-30 Sales Market Share in Volume by Application (2027-2032) Table 58. Global Tetrapeptide-30 Sales by Application (2027-2032) & (US$ Million) Table 59. Global Tetrapeptide-30 Sales Market Share in Value by Application (2027-2032) Table 60. Global Tetrapeptide-30 Price by Application (2027-2032) & (US$/g) Table 61. North America Tetrapeptide-30 Sales by Application (2021-2026) & (Kg) Table 62. North America Tetrapeptide-30 Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Tetrapeptide-30 Sales by Application (2021-2026) & (Kg) Table 64. Europe Tetrapeptide-30 Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Tetrapeptide-30 Sales by Application (2021-2026) & (Kg) Table 66. Asia-Pacific Tetrapeptide-30 Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Tetrapeptide-30 Sales by Application (2021-2026) & (Kg) Table 68. Latin America Tetrapeptide-30 Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Tetrapeptide-30 Sales by Application (2021-2026) & (Kg) Table 70. Middle East and Africa Tetrapeptide-30 Sales by Application (2021-2026) & (US$ Million) Table 71. GenScript Company Information Table 72. GenScript Business Overview Table 73. GenScript Tetrapeptide-30 Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 74. GenScript Tetrapeptide-30 Product Portfolio Table 75. GenScript Recent Development Table 76. Spec-Chem Company Information Table 77. Spec-Chem Business Overview Table 78. Spec-Chem Tetrapeptide-30 Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 79. Spec-Chem Tetrapeptide-30 Product Portfolio Table 80. Spec-Chem Recent Development Table 81. Uniproma Chemical Company Information Table 82. Uniproma Chemical Business Overview Table 83. Uniproma Chemical Tetrapeptide-30 Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 84. Uniproma Chemical Tetrapeptide-30 Product Portfolio Table 85. Uniproma Chemical Recent Development Table 86. Shenzhen JYMed Technology Company Information Table 87. Shenzhen JYMed Technology Business Overview Table 88. Shenzhen JYMed Technology Tetrapeptide-30 Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 89. Shenzhen JYMed Technology Tetrapeptide-30 Product Portfolio Table 90. Shenzhen JYMed Technology Recent Development Table 91. Zhejiang Peptites Biotech Company Information Table 92. Zhejiang Peptites Biotech Business Overview Table 93. Zhejiang Peptites Biotech Tetrapeptide-30 Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 94. Zhejiang Peptites Biotech Tetrapeptide-30 Product Portfolio Table 95. Zhejiang Peptites Biotech Recent Development Table 96. Winkey Technology Company Information Table 97. Winkey Technology Business Overview Table 98. Winkey Technology Tetrapeptide-30 Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 99. Winkey Technology Tetrapeptide-30 Product Portfolio Table 100. Winkey Technology Recent Development Table 101. Shenzhen Readline Biotech Company Information Table 102. Shenzhen Readline Biotech Business Overview Table 103. Shenzhen Readline Biotech Tetrapeptide-30 Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 104. Shenzhen Readline Biotech Tetrapeptide-30 Product Portfolio Table 105. Shenzhen Readline Biotech Recent Development Table 106. Bankpeptide Biological Technology Company Information Table 107. Bankpeptide Biological Technology Business Overview Table 108. Bankpeptide Biological Technology Tetrapeptide-30 Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 109. Bankpeptide Biological Technology Tetrapeptide-30 Product Portfolio Table 110. Bankpeptide Biological Technology Recent Development Table 111. Chengdu Youngshe Chemical Company Information Table 112. Chengdu Youngshe Chemical Business Overview Table 113. Chengdu Youngshe Chemical Tetrapeptide-30 Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 114. Chengdu Youngshe Chemical Tetrapeptide-30 Product Portfolio Table 115. Chengdu Youngshe Chemical Recent Development Table 116. North America Tetrapeptide-30 Market Size Growth Rate (CAGR) by Country (Kg): 2021 VS 2025 VS 2032 Table 117. North America Tetrapeptide-30 Sales by Country (2021-2026) & (Kg) Table 118. North America Tetrapeptide-30 Sales Market Share by Country (2021-2026) Table 119. North America Tetrapeptide-30 Sales Forecast by Country (2027-2032) & (Kg) Table 120. North America Tetrapeptide-30 Sales Market Share Forecast by Country (2027-2032) Table 121. North America Tetrapeptide-30 Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 122. North America Tetrapeptide-30 Market Size by Country (2021-2026) & (US$ Million) Table 123. North America Tetrapeptide-30 Market Share by Country (2021-2026) Table 124. North America Tetrapeptide-30 Market Size Forecast by Country (2027-2032) & (US$ Million) Table 125. North America Tetrapeptide-30 Market Share Forecast by Country (2027-2032) Table 126. Europe Tetrapeptide-30 Market Size Growth Rate (CAGR) by Country (Kg): 2021 VS 2025 VS 2032 Table 127. Europe Tetrapeptide-30 Sales by Country (2021-2026) & (Kg) Table 128. Europe Tetrapeptide-30 Sales Market Share by Country (2021-2026) Table 129. Europe Tetrapeptide-30 Sales Forecast by Country (2027-2032) & (Kg) Table 130. Europe Tetrapeptide-30 Sales Market Share Forecast by Country (2027-2032) Table 131. Europe Tetrapeptide-30 Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 132. Europe Tetrapeptide-30 Market Size by Country (2021-2026) & (US$ Million) Table 133. Europe Tetrapeptide-30 Market Share by Country (2021-2026) Table 134. Europe Tetrapeptide-30 Market Size Forecast by Country (2027-2032) & (US$ Million) Table 135. Europe Tetrapeptide-30 Market Share Forecast by Country (2027-2032) Table 136. Asia-Pacific Tetrapeptide-30 Market Size Growth Rate (CAGR) by Country (Kg): 2021 VS 2025 VS 2032 Table 137. Asia-Pacific Tetrapeptide-30 Sales by Country (2021-2026) & (Kg) Table 138. Asia-Pacific Tetrapeptide-30 Sales Market Share by Country (2021-2026) Table 139. Asia-Pacific Tetrapeptide-30 Sales Forecast by Country (2027-2032) & (Kg) Table 140. Asia-Pacific Tetrapeptide-30 Sales Market Share Forecast by Country (2027-2032) Table 141. Asia-Pacific Tetrapeptide-30 Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 142. Asia-Pacific Tetrapeptide-30 Market Size by Country (2021-2026) & (US$ Million) Table 143. Asia-Pacific Tetrapeptide-30 Market Share by Country (2021-2026) Table 144. Asia-Pacific Tetrapeptide-30 Market Size Forecast by Country (2027-2032) & (US$ Million) Table 145. Asia-Pacific Tetrapeptide-30 Market Share Forecast by Country (2027-2032) Table 146. Latin America Tetrapeptide-30 Market Size Growth Rate (CAGR) by Country (Kg): 2021 VS 2025 VS 2032 Table 147. Latin America Tetrapeptide-30 Sales by Country (2021-2026) & (Kg) Table 148. Latin America Tetrapeptide-30 Sales Market Share by Country (2021-2026) Table 149. Latin America Tetrapeptide-30 Sales Forecast by Country (2027-2032) & (Kg) Table 150. Latin America Tetrapeptide-30 Sales Market Share Forecast by Country (2027-2032) Table 151. Latin America Tetrapeptide-30 Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 152. Latin America Tetrapeptide-30 Market Size by Country (2021-2026) & (US$ Million) Table 153. Latin America Tetrapeptide-30 Market Share by Country (2021-2026) Table 154. Latin America Tetrapeptide-30 Market Size Forecast by Country (2027-2032) & (US$ Million) Table 155. Latin America Tetrapeptide-30 Market Share Forecast by Country (2027-2032) Table 156. Middle East and Africa Tetrapeptide-30 Market Size Growth Rate (CAGR) by Country (Kg): 2021 VS 2025 VS 2032 Table 157. Middle East and Africa Tetrapeptide-30 Sales by Country (2021-2026) & (Kg) Table 158. Middle East and Africa Tetrapeptide-30 Sales Market Share by Country (2021-2026) Table 159. Middle East and Africa Tetrapeptide-30 Sales Forecast by Country (2027-2032) & (Kg) Table 160. Middle East and Africa Tetrapeptide-30 Sales Market Share Forecast by Country (2027-2032) Table 161. Middle East and Africa Tetrapeptide-30 Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 162. Middle East and Africa Tetrapeptide-30 Market Size by Country (2021-2026) & (US$ Million) Table 163. Middle East and Africa Tetrapeptide-30 Market Share by Country (2021-2026) Table 164. Middle East and Africa Tetrapeptide-30 Market Size Forecast by Country (2027-2032) & (US$ Million) Table 165. Middle East and Africa Tetrapeptide-30 Market Share Forecast by Country (2027-2032) Table 166. Key Raw Materials Table 167. Raw Materials Key Suppliers Table 168. Tetrapeptide-30 Distributors List Table 169. Tetrapeptide-30 Customers List Table 170. Research Programs/Design for This Report Table 171. Authors List of This Report Table 172. Secondary Sources Table 173. Primary Sources List of Figures Figure 1. Tetrapeptide-30 Image Figure 2. Global Tetrapeptide-30 Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Tetrapeptide-30 Market Size (2021-2032) & (US$ Million) Figure 4. Global Tetrapeptide-30 Sales (2021-2032) & (Kg) Figure 5. Purity Above 98% Image Figure 6. Global Purity Above 98% Sales YoY Growth (2021-2032) & (Kg) Figure 7. Purity 98% Image Figure 8. Global Purity 98% Sales YoY Growth (2021-2032) & (Kg) Figure 9. Global Tetrapeptide-30 Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Tetrapeptide-30 Market Share by Type 2025 VS 2032 Figure 11. North America Tetrapeptide-30 Sales Market Share in Volume by Type in 2025 Figure 12. North America Tetrapeptide-30 Sales Market Share in Value by Type in 2025 Figure 13. Europe Tetrapeptide-30 Sales Market Share in Volume by Type in 2025 Figure 14. Europe Tetrapeptide-30 Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Tetrapeptide-30 Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Tetrapeptide-30 Sales Market Share in Value by Type in 2025 Figure 17. Latin America Tetrapeptide-30 Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Tetrapeptide-30 Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Tetrapeptide-30 Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Tetrapeptide-30 Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Tetrapeptide-30 Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Cream Image Figure 24. Global Cream Sales YoY Growth (2021-2032) & (Kg) Figure 25. Lotion Image Figure 26. Global Lotion Sales YoY Growth (2021-2032) & (Kg) Figure 27. Others Image Figure 28. Global Others Sales YoY Growth (2021-2032) & (Kg) Figure 29. Global Tetrapeptide-30 Market Size Overview by Application (2021-2032) & (US$ Million) Figure 30. Global Tetrapeptide-30 Market Share by Application 2025 VS 2032 Figure 31. North America Tetrapeptide-30 Sales Market Share in Volume by Application in 2025 Figure 32. North America Tetrapeptide-30 Sales Market Share in Value by Application in 2025 Figure 33. Europe Tetrapeptide-30 Sales Market Share in Volume by Application in 2025 Figure 34. Europe Tetrapeptide-30 Sales Market Share in Value by Application in 2025 Figure 35. Asia-Pacific Tetrapeptide-30 Sales Market Share in Volume by Application in 2025 Figure 36. Asia-Pacific Tetrapeptide-30 Sales Market Share in Value by Application in 2025 Figure 37. Latin America Tetrapeptide-30 Sales Market Share in Volume by Application in 2025 Figure 38. Latin America Tetrapeptide-30 Sales Market Share in Value by Application in 2025 Figure 39. Middle East and Africa Tetrapeptide-30 Sales Market Share in Volume by Application in 2025 Figure 40. Middle East and Africa Tetrapeptide-30 Sales Market Share in Value by Application in 2025 Figure 41. North America Tetrapeptide-30 Sales by Country: 2021 VS 2025 VS 2032 (Kg) Figure 42. North America Tetrapeptide-30 Sales Share by Country: 2021 VS 2025 VS 2032 Figure 43. North America Tetrapeptide-30 Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 44. North America Tetrapeptide-30 Market Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Tetrapeptide-30 Sales by Country: 2021 VS 2025 VS 2032 (Kg) Figure 46. Europe Tetrapeptide-30 Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Tetrapeptide-30 Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. Europe Tetrapeptide-30 Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific Tetrapeptide-30 Sales by Country: 2021 VS 2025 VS 2032 (Kg) Figure 50. Asia-Pacific Tetrapeptide-30 Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Tetrapeptide-30 Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Asia-Pacific Tetrapeptide-30 Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Tetrapeptide-30 Sales by Country: 2021 VS 2025 VS 2032 (Kg) Figure 54. Latin America Tetrapeptide-30 Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Tetrapeptide-30 Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Latin America Tetrapeptide-30 Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa Tetrapeptide-30 Sales by Country: 2021 VS 2025 VS 2032 (Kg) Figure 58. Middle East and Africa Tetrapeptide-30 Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Tetrapeptide-30 Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Middle East and Africa Tetrapeptide-30 Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Tetrapeptide-30 Value Chain Figure 62. Key Raw Materials Price Figure 63. Manufacturing Cost Structure Figure 64. Tetrapeptide-30 Production Mode & Process Figure 65. Direct Comparison with Distribution Share Figure 66. Distributors Profiles Figure 67. Years Considered Figure 68. Research Process Figure 69. Key Executives Interviewed

Scope & coverage.

Types
  • Purity Above 98%
  • Purity 98%
Applications
  • Cream
  • Lotion
  • Others
Companies covered
  • GenScript
  • Spec-Chem
  • Uniproma Chemical
  • Shenzhen JYMed Technology
  • Zhejiang Peptites Biotech
  • Winkey Technology
  • Shenzhen Readline Biotech
  • Bankpeptide Biological Technology
  • Chengdu Youngshe Chemical

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Tetrapeptide-30 Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Tetrapeptide-30 Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Tetrapeptide-30 Market by Type
  6. 1.3.1 Purity Above 98%
  7. 1.3.2 Purity 98%
  8. 1.4 Global Tetrapeptide-30 Market Size by Type
  9. 1.4.1 Global Tetrapeptide-30 Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Tetrapeptide-30 Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Tetrapeptide-30 Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Tetrapeptide-30 Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Tetrapeptide-30 Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Tetrapeptide-30 Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Tetrapeptide-30 Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Tetrapeptide-30 Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Tetrapeptide-30 Industry Trends
  2. 2.2 Tetrapeptide-30 Industry Drivers
  3. 2.3 Tetrapeptide-30 Industry Opportunities and Challenges
  4. 2.4 Tetrapeptide-30 Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Tetrapeptide-30 Revenue (2021-2026)
  2. 3.2 Global Top Players by Tetrapeptide-30 Sales (2021-2026)
  3. 3.3 Global Top Players by Tetrapeptide-30 Price (2021-2026)
  4. 3.4 Global Tetrapeptide-30 Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Tetrapeptide-30 Major Company Production Sites & Headquarters
  6. 3.6 Global Tetrapeptide-30 Company, Product Type & Application
  7. 3.7 Global Tetrapeptide-30 Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Tetrapeptide-30 Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Tetrapeptide-30 Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Tetrapeptide-30 Tier 1, Tier 2, and Tier 3
4 Tetrapeptide-30 Regional Status and Outlook
  1. 4.1 Global Tetrapeptide-30 Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Tetrapeptide-30 Historic Market Size by Region
  3. 4.2.1 Global Tetrapeptide-30 Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Tetrapeptide-30 Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Tetrapeptide-30 Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Tetrapeptide-30 Forecasted Market Size by Region
  7. 4.3.1 Global Tetrapeptide-30 Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Tetrapeptide-30 Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Tetrapeptide-30 Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Tetrapeptide-30 by Application
  1. 5.1 Tetrapeptide-30 Market by Application
  2. 5.1.1 Cream
  3. 5.1.2 Lotion
  4. 5.1.3 Others
  5. 5.2 Global Tetrapeptide-30 Market Size by Application
  6. 5.2.1 Global Tetrapeptide-30 Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Tetrapeptide-30 Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Tetrapeptide-30 Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Tetrapeptide-30 Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Tetrapeptide-30 Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Tetrapeptide-30 Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Tetrapeptide-30 Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Tetrapeptide-30 Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 GenScript
  2. 6.1.1 GenScript Company Information
  3. 6.1.2 GenScript Business Overview
  4. 6.1.3 GenScript Tetrapeptide-30 Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 GenScript Tetrapeptide-30 Product Portfolio
  6. 6.1.5 GenScript Recent Developments
  7. 6.2 Spec-Chem
  8. 6.2.1 Spec-Chem Company Information
  9. 6.2.2 Spec-Chem Business Overview
  10. 6.2.3 Spec-Chem Tetrapeptide-30 Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Spec-Chem Tetrapeptide-30 Product Portfolio
  12. 6.2.5 Spec-Chem Recent Developments
  13. 6.3 Uniproma Chemical
  14. 6.3.1 Uniproma Chemical Company Information
  15. 6.3.2 Uniproma Chemical Business Overview
  16. 6.3.3 Uniproma Chemical Tetrapeptide-30 Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Uniproma Chemical Tetrapeptide-30 Product Portfolio
  18. 6.3.5 Uniproma Chemical Recent Developments
  19. 6.4 Shenzhen JYMed Technology
  20. 6.4.1 Shenzhen JYMed Technology Company Information
  21. 6.4.2 Shenzhen JYMed Technology Business Overview
  22. 6.4.3 Shenzhen JYMed Technology Tetrapeptide-30 Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Shenzhen JYMed Technology Tetrapeptide-30 Product Portfolio
  24. 6.4.5 Shenzhen JYMed Technology Recent Developments
  25. 6.5 Zhejiang Peptites Biotech
  26. 6.5.1 Zhejiang Peptites Biotech Company Information
  27. 6.5.2 Zhejiang Peptites Biotech Business Overview
  28. 6.5.3 Zhejiang Peptites Biotech Tetrapeptide-30 Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Zhejiang Peptites Biotech Tetrapeptide-30 Product Portfolio
  30. 6.5.5 Zhejiang Peptites Biotech Recent Developments
  31. 6.6 Winkey Technology
  32. 6.6.1 Winkey Technology Company Information
  33. 6.6.2 Winkey Technology Business Overview
  34. 6.6.3 Winkey Technology Tetrapeptide-30 Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Winkey Technology Tetrapeptide-30 Product Portfolio
  36. 6.6.5 Winkey Technology Recent Developments
  37. 6.7 Shenzhen Readline Biotech
  38. 6.7.1 Shenzhen Readline Biotech Company Information
  39. 6.7.2 Shenzhen Readline Biotech Business Overview
  40. 6.7.3 Shenzhen Readline Biotech Tetrapeptide-30 Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Shenzhen Readline Biotech Tetrapeptide-30 Product Portfolio
  42. 6.7.5 Shenzhen Readline Biotech Recent Developments
  43. 6.8 Bankpeptide Biological Technology
  44. 6.8.1 Bankpeptide Biological Technology Company Information
  45. 6.8.2 Bankpeptide Biological Technology Business Overview
  46. 6.8.3 Bankpeptide Biological Technology Tetrapeptide-30 Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Bankpeptide Biological Technology Tetrapeptide-30 Product Portfolio
  48. 6.8.5 Bankpeptide Biological Technology Recent Developments
  49. 6.9 Chengdu Youngshe Chemical
  50. 6.9.1 Chengdu Youngshe Chemical Company Information
  51. 6.9.2 Chengdu Youngshe Chemical Business Overview
  52. 6.9.3 Chengdu Youngshe Chemical Tetrapeptide-30 Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Chengdu Youngshe Chemical Tetrapeptide-30 Product Portfolio
  54. 6.9.5 Chengdu Youngshe Chemical Recent Developments
7 North America by Country
  1. 7.1 North America Tetrapeptide-30 Sales by Country
  2. 7.1.1 North America Tetrapeptide-30 Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Tetrapeptide-30 Sales by Country (2021-2026)
  4. 7.1.3 North America Tetrapeptide-30 Sales Forecast by Country (2027-2032)
  5. 7.2 North America Tetrapeptide-30 Market Size by Country
  6. 7.2.1 North America Tetrapeptide-30 Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Tetrapeptide-30 Market Size by Country (2021-2026)
  8. 7.2.3 North America Tetrapeptide-30 Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Tetrapeptide-30 Sales by Country
  2. 8.1.1 Europe Tetrapeptide-30 Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Tetrapeptide-30 Sales by Country (2021-2026)
  4. 8.1.3 Europe Tetrapeptide-30 Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Tetrapeptide-30 Market Size by Country
  6. 8.2.1 Europe Tetrapeptide-30 Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Tetrapeptide-30 Market Size by Country (2021-2026)
  8. 8.2.3 Europe Tetrapeptide-30 Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Tetrapeptide-30 Sales by Country
  2. 9.1.1 Asia-Pacific Tetrapeptide-30 Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Tetrapeptide-30 Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Tetrapeptide-30 Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Tetrapeptide-30 Market Size by Country
  6. 9.2.1 Asia-Pacific Tetrapeptide-30 Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Tetrapeptide-30 Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Tetrapeptide-30 Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Tetrapeptide-30 Sales by Country
  2. 10.1.1 South America Tetrapeptide-30 Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Tetrapeptide-30 Sales by Country (2021-2026)
  4. 10.1.3 South America Tetrapeptide-30 Sales Forecast by Country (2027-2032)
  5. 10.2 South America Tetrapeptide-30 Market Size by Country
  6. 10.2.1 South America Tetrapeptide-30 Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Tetrapeptide-30 Market Size by Country (2021-2026)
  8. 10.2.3 South America Tetrapeptide-30 Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Tetrapeptide-30 Sales by Country
  2. 11.1.1 Middle East and Africa Tetrapeptide-30 Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Tetrapeptide-30 Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Tetrapeptide-30 Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Tetrapeptide-30 Market Size by Country
  6. 11.2.1 Middle East and Africa Tetrapeptide-30 Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Tetrapeptide-30 Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Tetrapeptide-30 Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Tetrapeptide-30 Value Chain Analysis
  2. 12.1.1 Tetrapeptide-30 Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Tetrapeptide-30 Production Mode & Process
  7. 12.2 Tetrapeptide-30 Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Tetrapeptide-30 Distributors
  10. 12.2.3 Tetrapeptide-30 Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst